Risk Prediction and New Prophylaxis Strategies for Thromboembolism in Cancer

by Patrizia Ferroni, Fiorella Guadagni, Mario Roselli
Published 2021-03-01

Predicting VTE in Cancer Patients: Candidate Biomarkers and Risk Assessment Models

by Silvia Riondino, Patrizia Ferroni, Fabio Massimo Zanzotto, Mario Roselli, Fiorella Guadagni
Published 2019-01-01

Type 2 Diabetes and Breast Cancer: The Interplay between Impaired Glucose Metabolism and Oxidant Stress

by Patrizia Ferroni, Silvia Riondino, Oreste Buonomo, Raffaele Palmirotta, Fiorella Guadagni, Mario Roselli
Published 2015-01-01

Venous Thromboembolism in Cancer Patients on Simultaneous and Palliative Care

by Silvia Riondino, Patrizia Ferroni, Girolamo Del Monte, Vincenzo Formica, Fiorella Guadagni, Mario Roselli
Published 2020-05-01

Breast Cancer Prognosis Using a Machine Learning Approach

by Patrizia Ferroni, Fabio M. Zanzotto, Silvia Riondino, Noemi Scarpato, Fiorella Guadagni, Mario Roselli
Published 2019-03-01

Validation of a Machine Learning Approach for Venous Thromboembolism Risk Prediction in Oncology

by Patrizia Ferroni, Fabio M. Zanzotto, Noemi Scarpato, Silvia Riondino, Fiorella Guadagni, Mario Roselli
Published 2017-01-01

Evans Syndrome Presented with Marginal Zone Lymphoma and Duodenal Neuroendocrine Tumor in an Elderly Woman

by Daniele D'Ambrosio, Valerio Tomaselli, Gaetano Gargiulo, Mario Roselli, David Della-Morte, Pasquale Abete
Published 2016-12-01

The Effects of Association of Topical Polydatin Improves the Preemptive Systemic Treatment on EGFR Inhibitors Cutaneous Adverse Reactions

by Mauro Bavetta, Dionisio Silvaggio, Elena Campione, Pietro Sollena, Vincenzo Formica, Deborah Coletta, Grazia Graziani, Maria Concetta Pucci Romano, Mario Roselli, Ketty Peris, Luca Bianchi
Published 2021-01-01

Insulin Resistance as a Risk Factor for Cutaneous Melanoma. A Case Control Study and Risk-Assessment Nomograms

by Alessandro Scoppola, Lidia Strigari, Agnese Barnabei, Pierpaolo Petasecca, Federica De Galitiis, Claudia Angela Maria Fulgenzi, Mario Roselli, Antonino De Lorenzo, Laura Di Renzo, Paolo Marchetti, Paolo Marchetti, Francesco Torino
Published 2019-11-01

Clinical Utility of Plasma KRAS, NRAS and BRAF Mutational Analysis with Real Time PCR in Metastatic Colorectal Cancer Patients—The Importance of Tissue/Plasma Discordant Cases

by Vincenzo Formica, Jessica Lucchetti, Elena Doldo, Silvia Riondino, Cristina Morelli, Renato Argirò, Nicola Renzi, Daniele Nitti, Antonella Nardecchia, Emanuela Dell’Aquila, Patrizia Ferroni, Fiorella Guadagni, Giampiero Palmieri, Augusto Orlandi, Mario Roselli
Published 2021-12-01

Relevance of computed tomography and magnetic resonance imaging for penile metastasis after prostatectomy: uncommon case report and brief review of the literature

by Valeria Fiaschetti, MD, PhD, Valeria Liberto, MD, Giulia Claroni, MD, Giorgio Loreni, MD, Vincenzo Formica, MD, Mario Roselli, MD, PhD, Alessandro Mauriello, MD, PhD, Roberto Floris, MD, PhD
Published 2016-09-01

Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials

by Antonio Galvano, Dalila Scaturro, Giuseppe Badalamenti, Lorena Incorvaia, Sergio Rizzo, Luisa Castellana, Stefania Cusenza, Sofia Cutaia, Daniele Santini, Fiorella Guadagni, Mario Roselli, Stefania Gori, Mario Adelfio Latteri, Viviana Bazan, Letizia Mauro Giulia, Antonio Russo
Published 2019-10-01

Urine LOX-1 and Volatilome as Promising Tools towards the Early Detection of Renal Cancer

by Michela Murdocca, Francesco Torino, Sabina Pucci, Manuela Costantini, Rosamaria Capuano, Chiara Greggi, Chiara Polidoro, Giuseppina Somma, Valentina Pasqualetti, Yolande Ketchanji Mougang, Alexandro Catini, Giuseppe Simone, Roberto Paolesse, Augusto Orlandi, Alessandro Mauriello, Mario Roselli, Andrea Magrini, Giuseppe Novelli, Corrado Di Natale, Federica Carla Sangiuolo
Published 2021-08-01

Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study

by Giulia Bon, Laura Pizzuti, Valentina Laquintana, Rossella Loria, Manuela Porru, Caterina Marchiò, Eriseld Krasniqi, Maddalena Barba, Marcello Maugeri-Saccà, Teresa Gamucci, Rossana Berardi, Lorenzo Livi, Corrado Ficorella, Clara Natoli, Enrico Cortesi, Daniele Generali, Nicla La Verde, Alessandra Cassano, Emilio Bria, Luca Moscetti, Andrea Michelotti, Vincenzo Adamo, Claudio Zamagni, Giuseppe Tonini, Giacomo Barchiesi, Marco Mazzotta, Daniele Marinelli, Silverio Tomao, Paolo Marchetti, Maria Rosaria Valerio, Rosanna Mirabelli, Antonio Russo, Maria Agnese Fabbri, Nicola D’Ostilio, Enzo Veltri, Domenico Corsi, Ornella Garrone, Ida Paris, Giuseppina Sarobba, Francesco Giotta, Carlo Garufi, Marina Cazzaniga, Pietro Del Medico, Mario Roselli, Giuseppe Sanguineti, Isabella Sperduti, Anna Sapino, Ruggero De Maria, Carlo Leonetti, Angelo Di Leo, Gennaro Ciliberto, Rita Falcioni, Patrizia Vici
Published 2020-12-01

The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial

by Laura Pizzuti, Maddalena Barba, Marco Mazzotta, Eriseld Krasniqi, Marcello Maugeri-Saccà, Teresa Gamucci, Rossana Berardi, Lorenzo Livi, Corrado Ficorella, Clara Natoli, Enrico Cortesi, Daniele Generali, Nicla La Verde, Alessandra Cassano, Emilio Bria, Luca Moscetti, Andrea Michelotti, Vincenzo Adamo, Claudio Zamagni, Giuseppe Tonini, Domenico Sergi, Daniele Marinelli, Giancarlo Paoletti, Silverio Tomao, Andrea Botticelli, Paolo Marchetti, Nicola Tinari, Antonino Grassadonia, Maria Rosaria Valerio, Rosanna Mirabelli, Maria Agnese Fabbri, Nicola D’Ostilio, Enzo Veltri, Domenico Corsi, Ornella Garrone, Ida Paris, Giuseppina Sarobba, Icro Meattini, Mirco Pistelli, Francesco Giotta, Vito Lorusso, Carlo Garufi, Antonio Russo, Marina Cazzaniga, Pietro Del Medico, Mario Roselli, Angela Vaccaro, Letizia Perracchio, Anna di Benedetto, Theodora Daralioti, Isabella Sperduti, Ruggero De Maria, Angelo Di Leo, Giuseppe Sanguineti, Gennaro Ciliberto, Patrizia Vici
Published 2021-07-01